
Uniphar Investor Relations Material
Latest events

H2 2024
Uniphar
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Uniphar plc
Access all reports
Uniphar Public Limited Company is a diversified healthcare services provider, operating mainly in the Republic of Ireland, the United Kingdom, and on an international scale. The company functions through three primary divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. In the Commercial & Clinical segment, Uniphar offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers, alongside distribution and support services to medical device manufacturers. The Product Access division delivers services that facilitate access to pharmaco-medical products and treatments, establishing vital connections between manufacturers and healthcare stakeholders, as well as providing bespoke distribution partnerships for pharmaceutical partners. The Supply Chain & Retail division is involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons, and operates a network of pharmacies under various brands. Additionally, it provides a range of support services including pharmacy support, specialist nursing, infusion, medical device distribution, healthcare technology, data intelligence, consultancy, pharmaceutical advisory, medical affairs, online pharmacy, and product fostering services. The company is headquartered in Dublin, Ireland, and its shares are listed on the Irish Stock Exchange.
Key slides for Uniphar plc


H2 2024
Uniphar plc


H2 2024
Uniphar plc
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
UPR
Country
🇮🇪 Ireland